Bioinformatic Evaluations for Locating the microRNA Suppressing PI 3 K / AKT Pathway and Analysis in Prostate Cancer Cell Lines

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.

  2014cited by this paper
• The role of microRNA in castration-resistant prostate cancer.

  2014cited by this paper
• miR-29b moulds the tumour microenvironment to repress metastasis

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis

  2013cited by this paper
• MicroRNA target prediction and validation.

  2013cited by this paper
• Preclinical Development miRNA-29 b Suppresses Prostate Cancer Metastasis by Regulating Epithelial – Mesenchymal Transition Signaling

  2012cited by this paper
• miR-34 – a microRNA replacement therapy is headed to the clinic

  2012cited by this paper
• Evaluation of online miRNA resources for biomedical applications

  2012cited by this paper
• DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways

  2012cited by this paper
• Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion

  2012cited by this paper
• International variation in prostate cancer incidence and mortality rates.

  2012cited by this paper
• Developing therapeutic microRNAs for cancer

  2011cited by this paper
• Platinum Priority – Collaborative Review – Prostate Cancer MicroRNA in Prostate , Bladder , and Kidney Cancer : A Systematic Review

  2011cited by this paper
• Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives.

  2011cited by this paper
• MicroRNA biogenesis and cancer.

  2011cited by this paper
• PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.

  2010cited by this paper
• MicroRNA: Biogenesis, Function and Role in Cancer

  2010cited by this paper
• The microRNA miR-34 a inhibits prostate cancer stem cells and metastasis by directly repressing CD 44

  2010cited by this paper
• mimiRNA: a microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets

  2010cited by this paper
• MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells.

  2010cited by this paper
• The microRNA pathway and cancer

  2010cited by this paper
• PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.

  2010cited by this paper
• Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway.

  2009cited by this paper
• Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.

  2009cited by this paper
• Widespread deregulation of microRNA expression in human prostate cancer

  2008cited by this paper
• Drug discovery approaches targeting the PI3K/Akt pathway in cancer

  2008cited by this paper
• MicroRNA expression profiling in prostate cancer.

  2007cited by this paper
• RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo*

  2005cited by this paper

• tRNA‐derived fragments in gastric cancer: Biomarkers and functions

  2022cites this paper
• Bioinformatic-based Identification of MicroRNAs with Biomarker Potential in Colon Cancer from Microarray Data

  2021cites this paper
• Bioinformatically Prediction of the miRNAs Targeting BCL9,FRMD6 Genes in Colorectal Cancer

  2021cites this paper
• Prediction of miRNAs Targeting E 6 and E 7 Genes in Human Papillomavirus Types 16 and 18 in Cervical Cancer

  2020cites this paper